We performed a phenotypic screen focusing on antiproliferative agents in parallel with a gene-expression-based screen approach to identify molecules that impair cell proliferation by suppressing an EVI1 signature (Fig. 1A) in AML cells overexpressing EVI1 (EVI1High). Here, RUNX1 is linked to acute myeloid leukemia.